Investor Relations

Avantium is a leading technology company in the area of advanced high-throughput R&D with a focus on applications in the energy, chemicals and pharmaceutical industries. Building on our expertise and track record in these industries, we focus on developing products in two fields:

bio-based products: fuels and plastics
novel crystal forms of marketed drugs under patent

Our strategy is to progress our development programs and exploit the commercial value of our expanding patent portfolio by securing value-adding partnerships, while at the same time continuing to expand our cash generative services and tools business.

We operate our services and systems activities in two business units: Chemicals, comprising our services and systems for the energy and chemicals industries, and Pharma, comprising our services and systems for the pharmaceutical and biotechnology industries. Both business units have their own development programs.

Avantium has a unique international shareholder base. The following venture capital providers support our business:

Aescap Venture (Amsterdam, the Netherlands )

Alpinvest (Amsterdam, the Netherlands)

Capricorn Cleantech Fund (Leuven, Belgium)

DFJ Esprit (London, UK)

EDB Investments (Singapore)

ING Group (Amsterdam, the Netherlands)

Navitas Capital (Bilthoven, the Netherlands)